Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs ...

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...

13:57, Wed, Nov 12, 2025 Updated: 13:59, Wed, Nov 12, 2025 Every single item of clothing you own contains several symbols and people are only just realising what they mean. Article continues below ...

Facing backlash over recent policy wording, the Coast Guard moved Thursday to make one thing clear: "hate symbols" such as swastikas and nooses remain forbidden in the service. The Coast Guard ...

ACI's 30th Annual Conference on Drug & Medical Device Litigation is the most trusted and anticipated gathering for in-house counsel and leading legal minds across the life sciences industry. With 400+ ...

The U.S. Coast Guard has released a new, firmer policy addressing the display of hate symbols like swastikas and nooses just hours after it was publicly revealed that it made plans to describe them as ...

The U.S. Food and Drug Administration has issued a recall of glucose monitors used by those with diabetes for malfunctioning.

UCB, a global biopharmaceutical company, today announced it will present 21 abstracts at the American Epilepsy Society (AES) Annual Meeting (December 5-9, 2025). Data include primary efficacy and ...

YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic ...

The application is based on data from multiple subcutaneous (SC) administration sub-studies of lecanemab conducted as part of the Phase 3 Clarity AD open-label extension (OLE), following the 18-month ...

Recently, the California Board of Pharmacy announced changes to its drug labeling rules that will take effect on April 1, 2017. The Board of Pharmacy amended Section 1744 of Article 5 of Division 17 ...

UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...